ERIN BORNS: Open Payments
NPI 1639562630 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 22 payments from 16 companies in 2025. Trend: 2023 $578 · 2024 $324 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $140 |
| Adaptive Biotechnologies Corporation | 3 | $140 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Stemline Therapeutics Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| TriSalus Life Sciences, Inc. | 1 | $28 |
| Syndax Pharmaceuticals, Inc. | 1 | $23 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
Products named: clonoSEQ, FASENRA, Enhertu, Orserdu, LYNOZYFIC, KISQALI, TRINAV INFUSION SYSTEM, XPOVIO.
Industry payments across NE — which companies pay providers there.
